Eur Respir J. 2013 Jan;41(1):1-2. doi: 10.1183/09031936.00181812.
The ambition of the European Respiratory Journal.
Humbert M.
The ambition of the European Respiratory Journal.
Humbert M.
Eur Respir J. 2013 Jan;41(1):8-9. doi: 10.1183/09031936.00181212.
Chronic thromboembolic pulmonary hypertension: advances from bench to patient management.
Pepke-Zaba J, Hoeper MM, Humbert M.
Chronic thromboembolic pulmonary hypertension: advances from bench to patient management.
Pepke-Zaba J, Hoeper MM, Humbert M.
Eur Respir J. 2013 Jan;41(1):236-9. doi: 10.1183/09031936.00114212.
Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries?
Lévy M, Celermajer D, Szezepanski I, Boudjemline Y, Bonnet D.
Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries?
Lévy M, Celermajer D, Szezepanski I, Boudjemline Y, Bonnet D.
J Anat. 2013 Mar;222(3):349-57. doi: 10.1111/joa.12023. Epub 2013 Jan 15.
The pattern of the coronary arterial orifices in hearts with congenital malformations of the outflow tracts: a marker of rotation of the outflow tract during cardiac development?
Houyel L, Bajolle F, Capderou A, Laux D, Parisot P, Bonnet D.
The pattern of the coronary arterial orifices in hearts with congenital malformations of the outflow tracts: a marker of rotation of the outflow tract during cardiac development?
Houyel L, Bajolle F, Capderou A, Laux D, Parisot P, Bonnet D.
Chest. 2013 Feb 1;143(2):398-405.
Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma.
Grimaldi-Bensouda L, Zureik M, Aubier M, Humbert M, Levy J, Benichou J, Molimard M, Abenhaim L; Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group.
Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma.
Grimaldi-Bensouda L, Zureik M, Aubier M, Humbert M, Levy J, Benichou J, Molimard M, Abenhaim L; Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group.
Eur Respir J. 2013 Feb 8. [Epub ahead of print]
Chronic Thromboembolic Pulmonary Hypertension: Role of medical therapy.
Pepke-Zaba J, Jansa P, Kim NH, Naejie R, Simonneau G.
Chronic Thromboembolic Pulmonary Hypertension: Role of medical therapy.
Pepke-Zaba J, Jansa P, Kim NH, Naejie R, Simonneau G.
Circulation. 2013 Feb 12. [Epub ahead of print]
Imatinib Mesylate as Add-On Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study.
Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Galié N, Gómez-Sánchez MA, Grimminger F, Grünig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T, Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn DA, Ghofrani HA.
Imatinib Mesylate as Add-On Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study.
Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Galié N, Gómez-Sánchez MA, Grimminger F, Grünig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T, Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn DA, Ghofrani HA.
Ann Rheum Dis. 2013 Feb 20. [Epub ahead of print]
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.
Avouac J, Huscher D, Furst DE, Opitz CF, Distler O, Allanore Y; for the EPOSS group.
Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.
Avouac J, Huscher D, Furst DE, Opitz CF, Distler O, Allanore Y; for the EPOSS group.
Eur Respir J. 2013 Feb 8. [Epub ahead of print]
Pulmonary hypertension in antisynthetase syndrome: prevalence, etiology and survival.
Hervier B, Meyer A, Dieval C, Uzunhan Y, Devilliers H, Launay D, Canuet M, Têtu L, Agard C, Sibilia J, Hamidou M, Amoura Z, Nunes H, Benveniste O, Grenier P, Montani D, Hachulla E.
Pulmonary hypertension in antisynthetase syndrome: prevalence, etiology and survival.
Hervier B, Meyer A, Dieval C, Uzunhan Y, Devilliers H, Launay D, Canuet M, Têtu L, Agard C, Sibilia J, Hamidou M, Amoura Z, Nunes H, Benveniste O, Grenier P, Montani D, Hachulla E.
Circulation. 2013 Mar 12;127(10):1098-100. doi: 10.1161/CIRCULATIONAHA.113.001460.
Impression, sunset.
Humbert M.
Impression, sunset.
Humbert M.